Difference between revisions of "Chlorozotocin (DCNU)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin NCI Drug Dictionary]: A glucose-linked chloroethylnitrosourea...") |
m |
||
| Line 9: | Line 9: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Nitrosoureas]] | [[Category:Nitrosoureas]] | ||
| + | [[Category:Stub]] | ||
Latest revision as of 19:27, 6 November 2023
Mechanism of action
From the NCI Drug Dictionary: A glucose-linked chloroethylnitrosourea with potential antineoplastic activity. Chlorozotocin alkylates DNA and proteins, induces the formation of interstrand DNA and DNA-protein crosslinks, and causes DNA strand breakage, thereby damaging DNA and resulting in cell death. This agent has been shown to exhibit antitumor and immunomodulatory effects in cell lines and animal models. Chlorozotocin is a mutagen and is less myelotoxic than other nitrosoureas.
Also known as
- Generic names: DCNU, D-glucopyranose
- Brand name: Dome